KDM5B and hepatocellular carcinoma: Further research has revealed that the knockdown of KDM5B significantly inhibits the proliferation of hepatocellular carcinoma cells both in vivo and in vitro by arresting the cell cycle at the G1/S phase, partly by up-regulating P15 and P27 [29,30].